Figure 3.

C-reactive protein (CRP) at baseline and at the week 1 and 4 control visits in the whole group of patients, in responders and non-responders. There was a significant difference by repeated measures ANOVA between responders and non-responders (p = 0.044) and within groups (p < 0.001).

Cimmino et al. BMC Musculoskeletal Disorders 2011 12:94   doi:10.1186/1471-2474-12-94
Download authors' original image